Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction | Zendy

Kevin N. Sheth | Zendy; Nils Petersen | Zendy; Ken Cheung | Zendy; Jordan J. Elm | Zendy; Holly E. Hinson | Zendy; Bradley J. Molyneaux | Zendy; Lauren A. Beslow | Zendy; Gordon Sze | Zendy; J. Marc Simard | Zendy; W. Taylor Kimberly | Zendy

Open Access

Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction

Author(s) -

Kevin N. Sheth,

Nils Petersen,

Ken Cheung,

Jordan J. Elm,

Holly E. Hinson,

Bradley J. Molyneaux,

Lauren A. Beslow,

Gordon Sze,

J. Marc Simard,

W. Taylor Kimberly

Publication year - 2018

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.020365

Subject(s) - medicine , term (time) , stroke (engine) , brain infarction , myocardial infarction , cardiology , pediatrics , ischemia , physics , quantum mechanics , mechanical engineering , engineering

We aimed to determine whether subjects aged ≤70 years who were treated with intravenous glyburide (RP-1127; BIIB093; glibenclamide) would have better long-term outcomes than those who received placebo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research